Header Image:
An estimated 450,000 Canadians over 65 years of age have Alzheimer’s disease or related dementia.
Alzheimer’s disease impacts every aspect of a person’s life – from their behaviour, to their thoughts and emotions. For families and caregivers, it is heartbreaking to watch their loved one change and gradually slip away into a fog of memory loss and confusion.
There is currently no cure for Alzheimer’s disease and there is a lack of effective treatment and methods of early detection. However, with recent breakthroughs and a commitment to detect the disease before the symptoms are present, Robarts is leading the way in research that will lead to better diagnosis, treatment and ultimately, prevention of this devastating disease.
At Robarts Research Institute, we are committed to raising more than $1.5 million over the next five years to support a core team of researchers, who share a common goal to identify the earliest changes in the brain that lead to Alzheimer’s disease.
By supporting Alzheimer’s disease research at Robarts, you will help us to:
. Improve the outcome for individuals with Alzheimer’s disease.
. Identify people early on so that when cures become available, they can access them.
. Decrease the economic burden the disease places on families and our healthcare system.
For more information about how you can make a difference, please contact:
Tara Kenney
Development Officer, Robarts Research Institute
The University of Western Ontario
PO Box 5015, 100 Perth Dr.
London, Ontario, Canada N6A 5K8
Tel: 519-931-5276 Fax: 519-931-5220
E-mail: tkenney@robarts.ca
or